Behavioral and monoamine changes following severe vitamin C deficiency

Journal of Neurochemistry

Volumn 124, Issue 3, 2013, Pages 363-375

  Ward, Margaret S ^a   Lamb, Jonathan ^a   May, James M ^b   Harrison, Fiona E ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

behavior; dopamine; oxidative stress; scurvy; serotonin; vitamin C

Indexed keywords

ASCORBIC ACID; DOPAMINE; GLUCOSE; LIPID; MONOAMINE; PROTEIN; SEROTONIN; SUCROSE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCORBIC ACID DEFICIENCY; BEHAVIOR CHANGE; BIOCHEMISTRY; BRAIN CORTEX; CATECHOLAMINERGIC SYSTEM; CONTROLLED STUDY; DEPRESSION; DOPAMINE BRAIN LEVEL; FEMALE; FOOD DEPRIVATION; FOOD PREFERENCE; GLUCOSE BLOOD LEVEL; LOCOMOTION; MALE; MONOAMINE METABOLISM; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SEROTONIN BRAIN LEVEL; SEROTONINERGIC SYSTEM; SOCIAL DOMINANCE; VITAMIN INTAKE; VITAMIN METABOLISM; VOLUNTARY MOVEMENT; WEAKNESS;

ANIMALS; ASCORBIC ACID; ASCORBIC ACID DEFICIENCY; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; DISEASE MODELS, ANIMAL; FEMALE; L-GULONOLACTONE OXIDASE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SEVERITY OF ILLNESS INDEX;

GULO; MUS;

EID: 84872063334     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12069     Document Type: Article

References (46)

1. Binfare R. W., Rosa A. O., Lobato K. R., Santos A. R., and, Rodrigues A. L., (2009) Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 530-540.
2. Bornstein S. R., Yoshida-Hiroi M., Sotiriou S., Levine M., Hartwig H. G., Nussbaum R. L., and, Eisenhofer G., (2003) Impaired adrenal catecholamine system function in mice with deficiency of the ascorbic acid transporter (SVCT2). FASEB J. 17, 1928-1930.
3. Brody S., (2002) High-dose ascorbic acid increases intercourse frequency and improves mood: a randomized controlled clinical trial. Biol. Psychiatry 52, 371-374.
4. Cahill L., Corey P. N., and, El-Sohemy A., (2009) Vitamin C deficiency in a population of young Canadian adults. Am. J. Epidemiol. 170, 464-471.
5. Chang C. W., Chen M. J., Wang T. E., Chang W. H., Lin C. C., and, Liu C. Y., (2007) Scurvy in a patient with depression. Dig. Dis. Sci. 52, 1259-1261.
6. Chapman J. M., and, Marley J. J., (2011) Scurvy and the ageing population. Br. Dent. J. 211, 583-584.
7. Chen K., Suh J., Carr A. C., Morrow J. D., Zeind J., and, Frei B., (2000) Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overload. Am. J. Physiol. Endocrinol. Metab. 279, E1406-E1412.
8. Chen Y., Curran C. P., Nebert D. W., Patel K. V., Williams M. T., and, Vorhees C. V., (2012) Effect of vitamin C deficiency during postnatal development on adult behavior: functional phenotype of Gulo(-/-) knockout mice. Genes Brain Behav. 11, 269-277.
9. Corpe C. P., Tu H., Eck P., et al,. (2010) Vitamin C transporter Slc23a1 links renal reabsorption, vitamin C tissue accumulation, and perinatal survival in mice. J. Clin. Investig. 120, 1069-1083.
10. Deana R., Bharaj B. S., Verjee Z. H., and, Galzigna L., (1975) Changes relevant to catecholamine metabolism in liver and brain of ascorbic acid deficient guinea-pigs. Int. J. Vitam. Nutr. Res. 45, 175-182.
11. Drago A., Crisafulli C., Sidoti A., and, Serretti A., (2011) The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes. Prog. Neurobiol. 94, 418-460.
12. Furusawa H., Sato Y., Tanaka Y., et al,. (2008) Vitamin C is not essential for carnitine biosynthesis in vivo: verification in vitamin C-depleted senescence marker protein-30/gluconolactonase knockout mice. Biol. Pharm. Bull. 31, 1673-1679.
13. Haenisch B., and, Bonisch H., (2011) Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters. Pharmacol. Ther. 129, 352-368.
14. Hampl J. S., Taylor C. A., and, Johnston C. S., (2004) Vitamin C deficiency and depletion in the United States: the Third National Health and Nutrition Examination Survey, 1988 to 1994. Am. J. Public Health 94, 870-875.
15. Harrison F. E., (2012) A critical review of vitamin C for the prevention of age-related cognitive decline and Alzheimer's disease. J. Alzheimers Dis. 29, 711-726.
16. Harrison F. E., and, May J. M., (2009) Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radical Biol. Med. 46, 719-730.
17. Harrison F. E., Yu S. S., Van Den Bossche K. L., Li L., May J. M., and, McDonald M. P., (2008) Elevated oxidative stress and sensorimotor deficits but normal cognition in mice that cannot synthesize ascorbic acid. J. Neurochem. 106, 1198-1208.
18. Harrison F. E., Hosseini A. H., Dawes S. M., Weaver S., and, May J. M., (2009a) Ascorbic acid attenuates scopolamine-induced spatial learning deficits in the water maze. Behav. Brain Res. 205, 550-558.
19. Harrison F. E., Hosseini A. H., and, McDonald M. P., (2009b) Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory tasks. Behav. Brain Res. 198, 247-251.
20. Harrison F. E., May J. M., and, McDonald M. P., (2010a) Vitamin C deficiency increases basal exploratory activity but decreases scopolamine-induced activity in APP/PSEN1 transgenic mice. Pharmacol. Biochem. Behav. 94, 543-552.
21. Harrison F. E., Meredith M. E., Dawes S. M., Saskowski J. L., and, May J. M., (2010b) Low ascorbic acid and increased oxidative stress in gulo(-/-) mice during development. Brain Res. 1349, 143-152.
22. Hawkins C. L., Morgan P. E., and, Davies M. J., (2009) Quantification of protein modification by oxidants. Free Radical Biol. Med. 46, 965-988.
23. Heseker H., Kubler W., Pudel V., and, Westenhofer J., (1995) Interaction of vitamins with mental performance. Bibl. Nutr. Dieta 52, 43-55.
24. Hori S., (1975) Effects of sulfhydryl agents on the activation of tryptophan-5-monooxygenase from bovine pineal glands. Biochim. Biophys. Acta 384, 58-68.
25. Hughes R. N., Lowther C. L., and, van Nobelen M., (2011) Prolonged treatment with vitamins C and E separately and together decreases anxiety-related open-field behavior and acoustic startle in hooded rats. Pharmacol. Biochem. Behav. 97, 494-499.
26. Johnston C. S., and, Thompson L. L., (1998) Vitamin C status of an outpatient population. J. Am. Coll. Nutr. 17, 366-370.
27. Johnston C. S., Solomon R. E., and, Corte C., (1998) Vitamin C status of a campus population: college students get a C minus. J. Am. Coll. Health 46, 209-213.
28. Kaufmann P., Wiens W., Dirks M., and, Krehbiel D., (1986) Changes in social behavior and brain catecholamines during the development of ascorbate deficiency in guinea pigs. Behav. Process. 13, 13-28.
29. Kinsman R. A., and, Hood J., (1971) Some behavioral effects of ascorbic acid deficiency. Am. J. Clin. Nutr. 24, 455-464.
30. Kobayashi K., Morita S., Sawada H., Mizuguchi T., Yamada K., Nagatsu I., Hata T., Watanabe Y., Fujita K., and, Nagatsu T., (1995) Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J. Biol. Chem. 270, 27235-27243.
31. Lind J., (1772) A Treatise on the Scurvy. S. Crowder etc, London.
32. Lindzey G., Winston H., and, Manosevitz M., (1961) Social dominance in inbred mouse strains. Nature 191, 474-476.
33. Moretti M., Colla A., de Oliveira Balen G., dos Santos D. B., Budni J., de Freitas A. E., Farina M., and, Severo Rodrigues A. L., (2012) Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress. J. Psychiatr. Res. 46, 331-340.
34. Nelson P. J., Pruitt R. E., Henderson L. L., Jenness R., and, Henderson L. M., (1981) Effect of ascorbic acid deficiency on the in vivo synthesis of carnitine. Biochim. Biophys. Acta 672, 123-127.
35. Oishi J., Doi H., and, Kawakami N., (2009) Nutrition and depressive symptoms in community-dwelling elderly persons in Japan. Acta Med. Okayama 63, 9-17.
36. Porsolt R. D., Bertin A., and, Jalfre M., (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229, 327-336.
37. Rebec G. V., and, Pierce R. C., (1994) A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog. Neurobiol. 43, 537-565.
38. Rebouche C. J., (1991) Ascorbic acid and carnitine biosynthesis. Am. J. Clin. Nutr. 54, 1147S-1152S.
39. Sanacora G., Treccani G., and, Popoli M., (2012) Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62, 63-77.
40. Savini I., Rossi A., Pierro C., Avigliano L., and, Catani M. V., (2008) SVCT1 and SVCT2: key proteins for vitamin C uptake. Amino Acids 34, 347-355.
41. Seitz G., Gebhardt S., Beck J. F., Bohm W., Lode H. N., Niethammer D., and, Bruchelt G., (1998) Ascorbic acid stimulates DOPA synthesis and tyrosine hydroxylase gene expression in the human neuroblastoma cell line SK-N-SH. Neurosci. Lett. 244, 33-36.
42. Smith A. P., Clark R. E., Nutt D. J., Haller J., Hayward S. G., and, Perry K., (1999) Vitamin C, mood and cognitive function in the elderly. Nutr. Neurosci. 2, 249-256.
43. Smith A., Di Primio G., and, Humphrey-Murto S., (2011) Scurvy in the developed world. CMAJ 183, E752-E755.
44. Stone K. J., and, Townsley B. H., (1973) The effect of L-ascorbate on catecholamine biosynthesis. Biochem. J. 131, 611-613.
45. Viggiano D., Ruocco L. A., and, Sadile A. G., (2003) Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder. Neurosci. Biobehav. Rev. 27, 623-637.
46. Viggiano D., Ruocco L. A., Arcieri S., and, Sadile A. G., (2004) Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder. Neural Plast. 11, 133-149.